For: | Ide R, Oshita A, Nishisaka T, Nakahara H, Aimitsu S, Itamoto T. Primary biliary cholangitis metachronously complicated with combined hepatocellular carcinoma-cholangiocellular carcinoma and hepatocellular carcinoma. World J Hepatol 2017; 9(36): 1378-1384 [PMID: 29359023 DOI: 10.4254/wjh.v9.i36.1378] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v9/i36/1378.htm |
Number | Citing Articles |
1 |
Takaomi SEKI, Norihumi HARIMOTO, Kenichiro ARAKI, Akira WATANABE, Hayato IKOTA, Ken SHIRABE. A Case of Multidisciplinary Treatment for Hepatocellular Carcinoma and Combined Hepatocellular Carcinoma-Cholangiocellular Carcinoma. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2020; 81(4): 736 doi: 10.3919/jjsa.81.736
|
2 |
Ling Gao, Jia-Yan Huang, Zi-Jian Lu, Qiang Lu. Contrast-enhanced ultrasound manifestations of synchronous combined hepatocellular-cholangiocarcinoma and hepatocellular carcinoma: A case report. World Journal of Clinical Cases 2022; 10(11): 3615-3623 doi: 10.12998/wjcc.v10.i11.3615
|
3 |
Erika Y. Faraoni, Cynthia Ju, Simon C. Robson, Holger K. Eltzschig, Jennifer M. Bailey-Lundberg. Purinergic and Adenosinergic Signaling in Pancreatobiliary Diseases. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.849258
|
4 |
Huilian Shi, Heng Dai, Qianqian Sun, Siliang Wang, Yuanyuan Chen. CD73, a significant protein in liver diseases. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1147782
|
5 |
Aleksandar Arsenijevic, Bojana Stojanovic, Jelena Milovanovic, Dragana Arsenijevic, Nebojsa Arsenijevic, Marija Milovanovic. Galectin-3 in Inflammasome Activation and Primary Biliary Cholangitis Development. International Journal of Molecular Sciences 2020; 21(14): 5097 doi: 10.3390/ijms21145097
|
6 |
Florian Roßner, Bruno Valentin Sinn, David Horst. Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update. Cancers 2023; 15(2): 494 doi: 10.3390/cancers15020494
|